Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
These combined signals indicate that the fever is likely a secondary response to a more serious internal issue
Regulatory & postmarketing journey Wegovys regulatory trajectory began with its 2021 approval for chronic weight management in adults with obesity or overweight plus comorbidity, following the STEP program
The Precision Peptide Genetic Test reveals predispositions in GLP1R and other peptide-pathway variants that may influence how efficiently your body activates GLP-1 signaling
Your PlexusDx provider customizes this timeline based on your individual tolerance and goals
If your genetic profile shows a less-favorable variant in MC4R or combined unfavorable patterns across multiple pathways, your body may adapt faster to GLP-1 and GIP stimulation
Healthcare providers can address underlying health factors that might affect treatment success while providing ongoing support and guidance throughout the process
